New Studies
Major findings from Lancet, BMJ, NEJM, JAMA, and other leading journals
Monoclonal antibody cliramitug shows sustained benefit in cardiac amyloidosis over 29 months
Long-term follow-up of the NI006-101 trial shows that cliramitug, a monoclonal antibody targeting misfolded transthyretin, sustains clinical benefit in cardiac…
Editor's Top Picks
AI-Assisted Clinical Decision Support Shows No Benefit Over Standard Care in Kenyan Primary Care Study
A pragmatic cluster-randomized trial in Kenya found that ChatGPT-4o-assisted clinical decision support did not significantly reduce treatment failure rates in…
Submit Your Paper →
More form New Studies
Correction issued for MAGE-A4/A8 immunotherapy trial in advanced solid tumours
Nature Medicine has published an author correction to a phase 1 trial investigating MAGE-A4/MAGE-A8-targeted T…
Jackfruit-derived biomaterial shows promise in reversing severe gum disease damage
A composite biomaterial combining jackfruit latex, pomegranate peel extract, and simvastatin has demonstrated early preclinical…
Scientists Reprogram Brain Immune Cells to Combat Alzheimer’s Disease
Researchers have identified a molecule called OLE that restores protective function in brain immune cells…
Flavanols in fruits and vegetables offer measurable cardiovascular protection, research shows
Consuming five daily servings of fruits and vegetables may not provide optimal cardiovascular protection unless…
Tiny genetic fragments control sleep-wake cycles, study finds
Researchers at Pompeu Fabra University and the Center for Genomic Regulation have identified tiny genetic…

